Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OTTMUSG00000016611 Inhibitors

The inhibition of the protein KRAB box and zinc finger, C2H2 type domain containing protein (Gm14434) can be achieved through the utilization of specific chemical compounds with well-established mechanisms of action. Among the selected chemicals, A769662, a selective activator of AMP-activated protein kinase (AMPK), can play a pivotal role in influencing cellular processes linked to Gm14434. Activation of AMPK, induced by A769662, has the potential to disrupt related pathways and cascades, ultimately leading to the functional inhibition of Gm14434 within the cellular context. Y-27632, a potent inhibitor of Rho-associated protein kinase (ROCK), can indirectly impact Gm14434 by interfering with various signaling pathways. Inhibition of ROCK by Y-27632 may disrupt signaling cascades and processes associated with Gm14434, potentially leading to its functional inhibition. Similarly, SB203580, a specific inhibitor of p38 mitogen-activated protein kinase (MAPK), possesses the capacity to influence cellular processes closely related to Gm14434. Inhibition of the MAPK pathway by SB203580 can result in the perturbation of signaling networks and processes, indirectly affecting Gm14434 and contributing to its functional inhibition.

AG1478, by inhibiting epidermal growth factor receptor (EGFR), can impact signaling pathways that indirectly interact with Gm14434. The disruption of these pathways through AG1478 may contribute to the functional inhibition of Gm14434. U73122, a phospholipase C (PLC) inhibitor, can potentially influence Gm14434 by targeting signaling pathways essential for cellular functions. Its inhibition may disrupt the intricate network of processes linked to Gm14434, contributing to its functional inhibition. Collectively, these selected chemicals offer a diverse array of mechanisms through which they can potentially inhibit the protein Gm14434. Their potential to influence specific pathways, signaling cascades, and cellular processes intricately associated with Gm14434's function underscores the possibility of functional inhibition, opening avenues for further investigation and experimental validation of their inhibitory effects on this protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$184.00
$741.00
$1076.00
$3417.00
$5304.00
23
(2)

A769662 is a selective activator of AMP-activated protein kinase (AMPK). Activation of AMPK can influence cellular processes related to Gm14434, potentially leading to its functional inhibition. Experimental validation is required.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a potent inhibitor of Rho-associated protein kinase (ROCK), which plays a role in various signaling pathways. Inhibition of ROCK can indirectly affect Gm14434 by disrupting related pathways. Further research is necessary for confirmation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 mitogen-activated protein kinase (MAPK), which can influence cellular processes linked to Gm14434. This inhibition may result in functional inhibition of Gm14434. Experimental verification is needed.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits the MAPK/ERK pathway, which is involved in various cellular processes. Inhibition of this pathway may indirectly affect Gm14434 by disrupting related cascades. Validation through experiments is essential.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor, impacting signaling pathways crucial for cellular functions. Its inhibition can potentially influence Gm14434 through related pathways. Experimental verification is necessary.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 also targets PI3K, potentially disrupting signaling cascades related to Gm14434. Inhibition of PI3K may lead to the functional inhibition of Gm14434. Experimental validation is required.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 inhibits the MEK/ERK pathway, which is involved in numerous cellular processes. This inhibition may indirectly affect Gm14434 by disrupting the related cascades. Validation through experiments is essential.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a selective inhibitor of c-Jun N-terminal kinase (JNK), which plays a role in signaling pathways. Inhibition of JNK can influence cellular processes linked to Gm14434, potentially resulting in its functional inhibition. Experimental verification is needed.

Tyrphostin AG 1478

175178-82-2sc-200613
sc-200613A
5 mg
25 mg
$96.00
$421.00
16
(1)

AG1478 inhibits epidermal growth factor receptor (EGFR), impacting signaling pathways that could indirectly affect Gm14434 by disrupting its associated cascades. Confirmation through experiments is essential.